GC BIOPHARMA CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111,900 KRW | +0.72% |
|
+2.57% | -10.84% |
ETFs positioned on GC Biopharma Corp.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 2 M€ | -14.14% | ||
| 0.05% | 2 M€ | -.--% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 7 M€ | +1.95% | - | |
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Green Cross Corp is a Korea-based company that mainly engaged in the manufacture and sale of pharmaceutical products. The Company mainly manufactures pharmaceutical products including blood products, general products, vaccines, over the counter (OTC) drugs, diagnostic reagents, placental injections, cell therapies, vaccine fertilized eggs and blood diagnostic products, among others. The Company also provides genome analysis services.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
111,900
KRW
Average target price
144,667
KRW
Spread / Average Target
+29.28%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -10.84% | 928M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- A006280 Stock
- Funds and ETFs GC Biopharma Corp.
